Adrenal Incidentalomas, 2003 to 2005: Experience after Publication of the National Institutes of Health Consensus Statement

Eldeiry, Leslie S.; Garber, Jeffrey R.

doi:10.4158/ep.14.3.279

Cited by 23 publications

(21 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…With regard to other studies in this field, both Herrera et al and Eldiery et al [6,7] adopted a similar approach to our own with large patient cohorts, reporting prevalence rates of 0.4 and 2.5%, respectively, for AI with CT scanning. The novel aspect of our study is its illustration of the difference between rates of AI derived from dedicated research protocols and those derived from clinical practice, moving the focus to the latter, which has greater clinical relevance.…”

Section: Discussionmentioning

confidence: 82%

“…Although we cannot extrapolate this aspect of our data to other centres, it nonetheless raises the concern that hormonally active tumours may escape diagnosis in hospitals that do not have a formal protocol in place for the assessment of AI. Interestingly, Eldeiry et al [7] also reported a significant percentage of patients who did not undergo endocrine investigations, and recommended increased education of clinicians regarding AI. Our data, gathered 3 years later, suggests that there may have been little improvement in adherence to international recommendations over this time.…”

Section: Discussionmentioning

confidence: 96%

See 1 more Smart Citation

The prevalence of adrenal incidentaloma in routine clinical practice

et al. 2011

View full text Add to dashboard Cite

The prevalence of adrenal incidentaloma (AI) on computed tomography (CT) in the general population has been reported to be as high as 4.2%. However, many of the previous studies in this field utilised a prospective approach with analysis of CT scans performed by one or more radiologists with a specialist interest in adrenal tumours and a specific focus on identifying the presence of an adrenal mass. A typical radiology department, with a focus on the patient's presenting complaint as opposed to the adrenal gland, may not be expected to diagnose as many adrenal incidentalomas as would be identified in a dedicated research protocol. We hypothesised that the number of AI reported in routine clinical practice is significantly lower than the published figures would suggest. We retrospectively reviewed the reports of all CT thorax and abdomen scans performed in our hospital over a 2 year period. 3,099 patients underwent imaging, with 3,705 scans performed. The median age was 63 years (range 18-98). Thirty-seven true AI were diagnosed during the time period studied. Twenty-two were diagnosed by CT abdomen (22/2,227) and 12 by CT thorax (12/1,478), a prevalence of 0.98 and 0.81% with CT abdomen and thorax, respectively, for AI in routine clinical practice.

show abstract

Section: Discussionmentioning

confidence: 82%

Section: Discussionmentioning

confidence: 96%

The prevalence of adrenal incidentaloma in routine clinical practice

et al. 2011

View full text Add to dashboard Cite

show abstract

“…Enlargement of an incidentaloma over time will occur in 9% [5], 14% [25], 25% [26], 26% [27], and 28% [28] in a time period up to 8 years [26]. Seventeen percent of incidentalomas classified as adenoma on radiological grounds in patients without clinically overt hormone secretion will increase in size over a mean duration of 24 months [29].…”

Section: Imagingmentioning

confidence: 95%

The indeterminate adrenal mass

Harrison

2011

Langenbecks Arch Surg

View full text Add to dashboard Cite

show abstract

“…Although several guidelines have been released over the years, 13,54,55 only 50% to 82% of patients diagnosed with AI undergo hormonal evaluations in clinical practice. 8,56,57 Subclinical Cushing Syndrome…”

Section: Biochemical Evaluation and Management Implicationsmentioning

confidence: 99%